Immunogen Inc. buy JPMorgan Chase & Co.
Start price
13.09.23
/
50%
€15.24
Target price
13.09.24
€20.50
Performance (%)
90.15%
Price
09.02.24
€28.97
Summary
This prediction is currently active. The BUY prediction by JPMorgan_Chase___Co_ for Immunogen Inc. has seen massive gains of 90.15%. This prediction currently runs until 13.09.24. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Immunogen Inc. | - | - |
| iShares Core DAX® | 0.476% | -0.039% |
| iShares Nasdaq 100 | 1.290% | 0.504% |
| iShares Nikkei 225® | 1.300% | -2.135% |
| iShares S&P 500 | 0.829% | 0.193% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Immunogen Inc. diskutieren
ImmunoGen, Inc. (NASDAQ: IMGN) was upgraded by analysts at JPMorgan Chase & Co. from a "neutral" rating to an "overweight" rating. They now have a $22.00 price target on the stock, up previously from $9.00.
Ratings data for IMGN provided by MarketBeat